BBSRC Portfolio Analyser
Award details
Synthesis of bryostatin scaffold molecules and studies of their interactions with protein kinase C
Reference
B09691
Principal Investigator / Supervisor
Professor Karl Joseph Hale
Co-Investigators /
Co-Supervisors
Professor Andy Gescher
,
Professor Gordon Roberts
Institution
University College London
Department
Chemistry
Funding type
Research
Value (£)
258,472
Status
Completed
Type
Research Grant
Start date
15/09/1998
End date
31/05/2002
Duration
45 months
Abstract
The ultimate aim of this project is to generate entirely novel and patentable anti- signalling drugs of potential use in the treatment of cancer. We propose to synthesise simplified analogues of the protein kinase C modulator bryostatin 1, and elucidate their mode of interaction with the enzyme to guide the synthesis of further analogues. Bryostatins, like phorbol esters, bind to cysteine-rich domains of PKC. We will define the 3D-solution structures of drug-PKC CRD complexes by high field NMR, and use this information to design other even more simplified yet highly potent PKC- modulators. These will be evaluated pharmacologically in animals in a subsequent study. Their cytostatic and cytotoxic effects in animals and cells will be determined, as will their immunostimulatory properties, and myalgic activity.
Summary
unavailable
Committee
Closed Committee - Biomolecular Sciences (BMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search